Gastroesophageal Reflux Disease
📧 Sign up to get email alerts when something new happens for Gastroesophageal Reflux Disease.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2016-08-01FDA Approved: PEPCID AC MAXIMUM STRENGTH — Supplemental Application (Kenvue Brands LLC)
FDA approved a supplemental application for PEPCID AC MAXIMUM STRENGTH (famotidine) by Kenvue Brands LLC, updating the product labeling as p…
-
CLINICAL_TRIALS trial_result · 2016-08-01Clinical Trial Update: Ph2a Study to Evaluate IW-3718 in Patients With Gastroesophageal Reflux Not Completely Responsive to Proton Pump Inhibitors [Phase 2]
Phase 2a study evaluating IW-3718 in patients with gastroesophageal reflux disease not fully controlled by proton pump inhibitors has comple…
-
FDA approval · 2016-07-25FDA Approved: LANSOPRAZOLE — Original Application (Xiromed LLC)
FDA approved the original application for a generic lansoprazole from Xiromed LLC.
-
FDA approval · 2016-07-15FDA Approved: OMEPRAZOLE AND SODIUM BICARBONATE — Original Application (Ajanta Pharma USA Inc.)
FDA approves Ajanta Pharma USA Inc.'s original-application generic combination of omeprazole and sodium bicarbonate for acid-related disorde…
-
FDA approval · 2016-07-15FDA Approved: EQUATE OMEPRAZOLE AND SODIUM BICARBONATE — Original Application (WALMART INC.)
FDA approved the original ANDA for Equate Omeprazole and Sodium Bicarbonate (Walmart Inc.), a store-brand combination proton pump inhibitor …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2016-07-12Clinical Trial Update: Image-Enhanced Endoscopy (IEE) for Diagnosis of Non-Erosive Reflux Disease
The trial evaluated image-enhanced endoscopy for diagnosing gastroesophageal reflux disease; the study status is completed.
-
FDA label_change · 2016-07-08FDA Approved: DEXILANT — Supplemental Application (Takeda Pharmaceuticals America, Inc.)
The FDA approved a supplemental application for Dexilant (dexlansoprazole) submitted by Takeda Pharmaceuticals America, Inc. The approval ma…
-
CLINICAL_TRIALS research · 2016-06-29Clinical Trial Update: Lesogaberan in Chinese Patients With Refractory Reflux Symptoms [Phase 2]
Phase 2 clinical trial update on lesogaberan in Chinese patients with refractory reflux symptoms; the current status is unknown.
-
CLINICAL_TRIALS trial_result · 2016-06-24Clinical Trial Update: Efficacy of Proton Pump Inhibitor for Chronic Cough Caused by Gastroesophageal Reflux; Double-blind, Placebo-controlled, Randomized Clinical Trial [NA]
This completed randomized, double-blind, placebo-controlled trial from Yonsei University evaluated the efficacy of a proton pump inhibitor f…
-
CLINICAL_TRIALS trial_result · 2016-06-21Clinical Trial Update: Effect of Magnesium Alginate on Gastroesophageal Reflux in Infants. [Phase 4]
This Phase 4 clinical trial assesses whether magnesium alginate reduces gastroesophageal reflux in infants; the current status is unknown.
-
FDA approval · 2016-06-17FDA Approved: NEXIUM 24HR CLEARMINIS — Supplemental Application (Haleon US Holdings LLC)
The FDA approved a supplemental application for Nexium 24HR ClearMINIS (esomeprazole magnesium) from Haleon US Holdings LLC.
-
FDA approval · 2016-06-08FDA Approved: PEPCID COMPLETE — Supplemental Application (Lil' Drug Store Products, Inc.)
FDA approved a supplemental application to market PEPCID COMPLETE, a chewable tablet that combines famotidine with calcium carbonate and mag…
-
FDA approval · 2016-06-07FDA Approved: EQUATE LANSOPRAZOLE — Original Application (Wal-Mart Stores Inc)
FDA approves Equate Lansoprazole (Wal-Mart Stores Inc) under an Original Application for lansoprazole.
-
CLINICAL_TRIALS trial_result · 2016-06-03Clinical Trial Update: Compound Sodium Alginate Oral Suspension Sachet Symptomatic Relief Study [Phase 3]
A Phase 3 clinical trial testing compound sodium alginate oral suspension for symptomatic relief in gastroesophageal reflux disease has comp…
-
FDA approval · 2016-06-01FDA Approved: LANSOPRAZOLE — Original Application (Rite Aid Corporation)
FDA approved an original-application generic lansoprazole (a proton pump inhibitor) as an approved product; Rite Aid Corporation was the app…
-
CLINICAL_TRIALS research · 2016-05-27Clinical Trial Update: Observational Study (This Means That no Drug is Tested) in Patients Suffering of Gastroesophageal Reflux Disease.
This document reports the completion of an observational clinical trial in patients with gastroesophageal reflux disease, noting that no dru…
-
FDA approval · 2016-05-05FDA Approved: PEPCID AC MAXIMUM STRENGTH — Supplemental Application (Kenvue Brands LLC)
FDA approved a supplemental application for Pepcid AC Maximum Strength (famotidine) submitted by Kenvue Brands LLC. The approval pertains to…
-
CLINICAL_TRIALS trial_result · 2016-05-03Clinical Trial Update: Treatment Effect Between Dexlansoprazole and Double-dose Lansoprazole in Obesity Patients With Reflux Esophagitis [Phase 4]
Phase 4 clinical trial comparing dexlansoprazole with double-dose lansoprazole in obesity-related reflux esophagitis; study status is unknow…
-
CLINICAL_TRIALS trial_result · 2016-05-02Clinical Trial Update: Nociceptors, Neurotrophic Factors and Cytokine Expression in Gastroesophageal Reflux Disease [NA]
This clinical trial examined nociceptors, neurotrophic factors, and cytokine expression in gastroesophageal reflux disease; results were pos…
-
CLINICAL_TRIALS trial_result · 2016-04-29Clinical Trial Update: A Study to Evaluate REbamiPide as an Adjuvant Regimen to Heal erosIve Reflux Esophagitis [Phase 4]
A Phase 4 study evaluating rebamipide as an adjuvant regimen to heal erosive esophagitis in gastroesophageal reflux disease has completed.
-
FDA approval · 2016-04-22FDA Approved: ESOMEPRAZOLE MAGNESIUM — Supplemental Application (NorthStar Rx LLC)
FDA approved a supplemental application for Esomeprazole Magnesium (generic esomeprazole magnesium) submitted by NorthStar Rx LLC.
-
FDA approval · 2016-04-21FDA Approved: ZEGERID OTC — Supplemental Application (Riley Consumer Care LLC)
FDA approves a supplemental application for ZEGERID OTC (omeprazole and sodium bicarbonate) submitted by Riley Consumer Care LLC.
-
FDA approval · 2016-04-21FDA Approved: ESOMEPRAZOLE MAGNESIUM — Original Application (Aurobindo Pharma Limited)
FDA approved the original application for esomeprazole magnesium from Aurobindo Pharma Limited, making a generic version of this proton pump…
-
CLINICAL_TRIALS research · 2016-04-07Clinical Trial Update: The Role of Gastroesophageal Reflux in Scleroderma Pulmonary Fibrosis
A clinical trial update evaluating the role of gastroesophageal reflux in scleroderma-related pulmonary fibrosis; current status is unknown.
-
FDA approval · 2016-04-04FDA Approved: PANTOPRAZOLE SODIUM — Supplemental Application (NorthStar Rx LLC)
The FDA approved a supplemental application for Pantoprazole Sodium from NorthStar Rx LLC under ANDA202038.